Zinc Transporters and Zinc Signaling: New Insights into Their Role in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Zinc is an essential trace element that plays a vital role in many biological processes including growth and development, immunity, and metabolism. Recent studies have highlighted zinc’s dynamic role as a “cellular second messenger” in the control of insulin signaling and glucose homeostasis. Accordingly, mechanisms that contribute to dysfunctional zinc signaling are suggested to be associated with metabolic disease states including cancer, cardiovascular disease, Alzheimer’s disease, and diabetes. The actions of the proteins that control the uptake, storage, and distribution of zinc, the zinc transporters, are under intense investigation due to their emerging role in type 2 diabetes. The synthesis, secretion, and action of insulin are dependent on zinc and the transporters that make this ion available to cellular processes. This suggests that zinc plays a previously unidentified role where changes in zinc status over time may affect insulin activity. This previously unexplored concept would raise a whole new area of research into the pathophysiology of insulin resistance and introduce a new class of drug target with utility for diabetes pharmacotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843 · cited 2×
“ZnT8 is suggested to be associated with the risk of T2D in humans due to a nonsynonymous SNP (rs13266634 C>T) which exchanges arginine (R) with tryptophan (W) at amino acid position 325 in European and Chinese patients [81–84].”
BackgroundZinc transporters and the cellular trafficking of zinc
Eide, D. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.03.005 · Cited by 874 · cited 1×
“Figure was adapted from Eide (2006) [30] and the image was produced using Servier Medical Art: http://www.”
MethodLoss-of-function mutations in SLC30A8 protect against type 2 diabetes
Go-T2D Consortium, Flannick, J., T2D-GENES Consortium, Thorleifsson, G., Beer, N. L., Jacobs, S. B. R., Grarup, N., Burtt, N. P., Mahajan, A., Fuchsberger, C., et al. (2014) · Nature Genetics · doi:10.1038/ng.2915 · Cited by 492 · cited 4×
“(2014) sequenced or genotyped approximately 150,000 individuals across five ethnicities and identified 12 rare, predicted ZnT8 protein truncation variants that conferred a 65% reduced risk of T2D [87].”
BackgroundInfluentialChimienti, F., Devergnas, S., Pattou, F., Schuit, F., Garcia-Cuenca, R., Vandewalle, B., Kerr-Conte, J., Van Lommel, L., Grunwald, D., Favier, A., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.03164 · Cited by 349 · cited 1×
“It has been shown that the overexpression of ZnT8 in INS-1 cells induces glucose-stimulated insulin secretion [76].”
BackgroundEffects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysis
Jayawardena, R., Ranasinghe, P., Galappatthy, P., Malkanthi, R., Constantine, G., & Katulanda, P. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-13 · Cited by 346
Imaging mobile zinc in biology
Tomat, E., & Lippard, S. J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.12.010 · Cited by 217
Cited by
Update on the treatment of type 2 diabetes mellitus
Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Cañizo-Gómez, F. J. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.354 · Cited by 647
“Recent studies have shown the dynamic role of zinc, an insulin mimetic, as a “cellular second messenger” in glucose homeostasis and in the control of insulin signaling [376] .”
BackgroundZinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism
Olechnowicz, J., Tinkov, A., Skalny, A., & Suliburska, J. (2018) · The Journal of Physiological Sciences · doi:10.1007/s12576-017-0571-7 · Cited by 557
Zinc and Diabetes: A Connection between Micronutrient and Metabolism
Ahmad, R., Shaju, R., Atfi, A., & Razzaque, M. S. (2024) · Cells · doi:10.3390/cells13161359 · Cited by 77
Zinc homeostasis and redox alterations in obesity
Franco, C., & Canzoniero, L. M. T. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1273177 · Cited by 31
“The mechanisms underlying these effects include the inhibition of protein tyrosine phosphatase 1B (PTP1B), which is physiologically responsible for insulin receptor inhibition through dephosphorylation and attenuates insulin signal transduction (123, 124).”
Background
Metadata
- Authors
- Myers, S. A.
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-7
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- OpenAlex
- W2006622114
- Cited by
- 50
- References
- 7
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zinc Transporters and Zinc Signaling: New Insights into Their Role in Type 2 Diabetes. https://app.cochat.ai/papers/10.1155/2015/167503
- The paper
- Myers, S. A. (2015). Zinc Transporters and Zinc Signaling: New Insights into Their Role in Type 2 Diabetes. International Journal of Endocrinology. https://doi.org/10.1155/2015/167503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.